Literature DB >> 186559

Long-term persistent vesicular stomatitis virus and rabies virus infection of cells in vitro.

J J Holland, L P Villarreal, R M Welsh, M B Oldstone, D Kohne, R Lazzarini, E Scolnick.   

Abstract

BHK 21 carrier cells persistently infected with VSV Indiana for over 2 years have been shedding generally very low levels of mature infectious virus or mature T particles (averaging less than one-hundredth p.f.u./cell/day) yet most cells are producing virus antigens and are resistant to homologous superinfection. However, large amounts of biologically active T particle RNP can be recovered from cytoplasmic extracts of these carrier cells even at times when they are shedding no detectable infectious virus. This recovered cytoplasmic RNP replicates (with helper B virions) to produce mature T particles, interferes strongly after DEAE dextran-facilitated uptake and, together with B virions, allows the establishment of a persistent carrier state in exposed cells. No 'provirus' DNA copies of the VSV RNA genome are detectable (less than 1/40 copy/cell or I copy per 40 cells) in carrier cells after more than 2 years of persistent infection, and all transfection attempts have failed using DNA from these VSV carriers or DNA from carrier cells persistently infected with some other negative strand RNA viruses (measles, mumps, LCM, influenza, rabies). Infectious viruses shed after more than I year from carrier cells originally infected with wild-type B virions are small plaque mutants showing a slight temperature sensitivity. Cured cell populations can be obtained from the long term VSV carrier culture by cloning in the presence or absence of antiviral antibody.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 186559     DOI: 10.1099/0022-1317-33-2-193

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  41 in total

1.  A microcarrier-based cell culture process for the production of a bovine respiratory syncytial virus vaccine.

Authors:  E Moran
Journal:  Cytotechnology       Date:  1999-03       Impact factor: 2.058

2.  Persistent vesicular stomatitis virus infection mediates base substitutions in viral RNA termini.

Authors:  B L Semler; J J Holland
Journal:  J Virol       Date:  1979-11       Impact factor: 5.103

Review 3.  Mechanisms of persistent infections by cytopathic viruses in tissue culture. Brief review.

Authors:  R M Friedman; J M Ramseur
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

4.  Sequence of a RNA templated by the 3'-OH RNA terminus of defective interfering particles of vesicular stomatitis virus.

Authors:  B L Semler; J Perrault; J Abelson; J J Holland
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

Review 5.  Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessment.

Authors:  David K Clarke; R Michael Hendry; Vidisha Singh; John K Rose; Stephen J Seligman; Bettina Klug; Sonali Kochhar; Lisa Marie Mac; Baevin Carbery; Robert T Chen
Journal:  Vaccine       Date:  2016-07-06       Impact factor: 3.641

Review 6.  Systemic lupus erythematosus: RNA-protein autoantigens, models of disease heterogeneity, and theories of etiology.

Authors:  J B Harley; R H Scofield
Journal:  J Clin Immunol       Date:  1991-11       Impact factor: 8.317

7.  Effect of antiviral antibody on maintenance of long-term rubella virus persistent infection in Vero cells.

Authors:  E S Abernathy; C Y Wang; T K Frey
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

8.  Trojan horse lymphocytes: a vesicular stomatitis virus-specific T-cell clone lyses target cells by carrying virus.

Authors:  R C Hom; G Soman; R Finberg
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

9.  Autoantigenicity of Ro/SSA antigen is related to a nucleocapsid protein of vesicular stomatitis virus.

Authors:  R H Scofield; J B Harley
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

10.  Persistent infection with mouse hepatitis virus 3 in mouse lymphoid cell lines.

Authors:  L M Lamontagne; J M Dupuy
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.